Home LiteratureArticle Details
PMID: 17963812 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins.

Virology ·Vol. 371 ·No. 2 ·2008-02-20 ·Pages 394-404

Sundstrom M, Chatterji U, Schaffer L, de Rozières S, Elder JH

Abstract

Expression of the feline immunodeficiency virus (FIV) accessory protein OrfA (or Orf2) is critical for efficient viral replication in lymphocytes, both in vitro and in vivo. OrfA has been reported to exhibit functions in common with the human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) accessory proteins Vpr and Tat, although the function of OrfA has not been fully explained. Here, we use microarray analysis to characterize how OrfA modulates the gene expression profile of T-lymphocytes. The primary IL-2-dependent T-cell line 104-C1 was transduced to express OrfA. Functional expression of OrfA was demonstrated by trans complementation of the OrfA-defective clone, FIV-34TF10. OrfA-expressing cells had a slightly reduced cell proliferation rate but did not exhibit any significant alteration in cell cycle distribution. Reverse-transcribed RNA from cells expressing green fluorescent protein (GFP) or GFP+OrfA were hybridized to Affymetrix HU133 Plus 2.0 microarray chips representing more than 47,000 genome-wide transcripts. By using two statistical approaches, 461 (Rank Products) and 277 (ANOVA) genes were identified as modulated by OrfA expression. The functional relevance of the differentially expressed genes was explored by Ingenuity Pathway Analysis. The analyses revealed alterations in genes critical for RNA post-transcriptional modifications and protein ubiquitination as the two most significant functional outcomes of OrfA expression. In these two groups, several subunits of the spliceosome, cellular splicing factors and family members of the proteasome-ubiquitination system were identified. These findings provide novel information on the versatile function of OrfA during FIV infection and indicate a fine-tuning mechanism of the cellular environment by OrfA to facilitate efficient FIV replication.

MeSH Terms
Animals Cats Cell Line Gene Expression Regulation Genome, Viral Humans Immunodeficiency Virus, Feline/pathogenicity,physiology Mice Nuclear Proteins/genetics,metabolism Oligonucleotide Array Sequence Analysis Open Reading Frames/genetics,physiology Proteasome Endopeptidase Complex/genetics,metabolism Proteins/genetics,metabolism T-Lymphocytes/virology Ubiquitin/genetics,metabolism Virus Replication
Chemicals
Nuclear Proteins Proteins Ubiquitin Proteasome Endopeptidase Complex
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sundstrom Magnus
Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Chatterji Udayan
Schaffer Lana
de Rozières Sohela
Elder John H
References (65)
65 references, click to expand
  1. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
    Blood. 1998 Nov 15;92(10):3780-92 PMID: 9808572
  2. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.
    J Virol. 2001 May;75(10):4528-39 PMID: 11312323
  3. Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators.
    J Virol. 2002 Oct;76(19):9624-34 PMID: 12208941
  4. The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor.
    J Biol Chem. 2007 Sep 14;282(37):27046-27057 PMID: 17620334
  5. Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing.
    Curr HIV Res. 2006 Jan;4(1):43-55 PMID: 16454710
  6. Relationship of lymphoid lesions to disease course in mucosal feline immunodeficiency virus type C infection.
    Vet Pathol. 2000 Sep;37(5):386-401 PMID: 11055861
  7. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.
    J Virol. 2007 Oct;81(19):10515-23 PMID: 17652391
  8. HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation.
    J Biol Chem. 1997 Mar 28;272(13):8145-8 PMID: 9079628
  9. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
    Genes Dev. 1998 Jul 15;12(14):2222-33 PMID: 9679066
  10. Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.
    Proc Natl Acad Sci U S A. 1989 Oct;86(20):8088-92 PMID: 2813380
  11. U2AF65 recruits a novel human DEAD box protein required for the U2 snRNP-branchpoint interaction.
    Genes Dev. 1997 Jul 15;11(14):1864-72 PMID: 9242493
  12. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection.
    Proc Natl Acad Sci U S A. 2006 May 9;103(19):7465-70 PMID: 16648264
  13. Molecular cloning of the cDNA for the human U2 snRNA-specific A' protein.
    Nucleic Acids Res. 1989 Mar 11;17(5):1893-906 PMID: 2928112
  14. Identification and characterization of differentially expressed mRNAs in HIV type 1-infected human T cells.
    AIDS Res Hum Retroviruses. 2000 Jul 1;16(10):995-1005 PMID: 10890361
  15. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.
    J Virol. 1993 Nov;67(11):6365-78 PMID: 8411338
  16. Primer3 on the WWW for general users and for biologist programmers.
    Methods Mol Biol. 2000;132:365-86 PMID: 10547847
  17. Adjusting batch effects in microarray expression data using empirical Bayes methods.
    Biostatistics. 2007 Jan;8(1):118-27 PMID: 16632515
  18. Human immunodeficiency virus type 1 hnRNP A/B-dependent exonic splicing silencer ESSV antagonizes binding of U2AF65 to viral polypyrimidine tracts.
    Mol Cell Biol. 2003 Dec;23(23):8762-72 PMID: 14612416
  19. HMGB1 activates replication of latent HIV-1 in a monocytic cell-line, but inhibits HIV-1 replication in primary macrophages.
    Cytokine. 2006 Apr;34(1-2):17-23 PMID: 16697213
  20. Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.
    Mol Cell Biol. 2006 Nov;26(21):8149-58 PMID: 16923959
  21. Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits.
    FEBS Lett. 2003 Oct 9;553(1-2):200-4 PMID: 14550573
  22. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine.
    J Vet Intern Med. 1993 Jan-Feb;7(1):34-9 PMID: 8384261
  23. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
    J Biol Chem. 2004 Jul 16;279(29):29963-73 PMID: 15123677
  24. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
    EMBO J. 2001 Oct 15;20(20):5748-58 PMID: 11598017
  25. FIV infection of IL-2-dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation.
    Vet Immunol Immunopathol. 1998 Oct 23;65(2-4):277-97 PMID: 9839880
  26. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.
    Science. 1989 Dec 22;246(4937):1606-8 PMID: 2556795
  27. HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA.
    J Biol Chem. 2001 Apr 20;276(16):12959-66 PMID: 11278368
  28. Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding.
    J Virol. 1997 Aug;71(8):5742-9 PMID: 9223460
  29. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.
    Biochem J. 2002 Jun 15;364(Pt 3):649-57 PMID: 12049628
  30. Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1.
    Biochem J. 2006 Jun 1;396(2):371-80 PMID: 16512786
  31. Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest.
    Virology. 2004 Aug 1;325(2):167-74 PMID: 15246256
  32. Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection.
    J Virol. 2005 May;79(9):5705-12 PMID: 15827185
  33. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.
    Curr Opin Immunol. 2004 Feb;16(1):76-81 PMID: 14734113
  34. Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats.
    J Virol. 1996 May;70(5):2894-901 PMID: 8627764
  35. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.
    Physiol Rev. 2002 Apr;82(2):373-428 PMID: 11917093
  36. Vertical transmission of feline immunodeficiency virus.
    Semin Vet Med Surg Small Anim. 1995 Nov;10(4):266-78 PMID: 8820602
  37. The strength of the HIV-1 3' splice sites affects Rev function.
    Retrovirology. 2006 Dec 04;3:89 PMID: 17144911
  38. cDNA cloning of the human U1 snRNA-associated A protein: extensive homology between U1 and U2 snRNP-specific proteins.
    EMBO J. 1987 Dec 1;6(12):3841-8 PMID: 2962859
  39. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
    Virology. 1992 Mar;187(1):165-77 PMID: 1310554
  40. Comparison of two host cell range variants of feline immunodeficiency virus.
    J Virol. 1990 Oct;64(10):4605-13 PMID: 1697907
  41. Potential role of high mobility group box 1 in viral infectious diseases.
    Viral Immunol. 2006 Spring;19(1):3-9 PMID: 16553546
  42. The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing.
    J Mol Biol. 2002 Nov 1;323(4):771-82 PMID: 12419264
  43. Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
    Virology. 1996 Jan 1;215(1):10-6 PMID: 8553580
  44. A paradigm for class prediction using gene expression profiles.
    J Comput Biol. 2002;9(3):505-11 PMID: 12162889
  45. Nucleotide sequence and genomic organization of feline immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1989 Aug;86(15):5743-7 PMID: 2762293
  46. Human immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibition.
    Microbes Infect. 2007 Apr;9(4):490-7 PMID: 17347016
  47. A novel function for Sam68: enhancement of HIV-1 RNA 3' end processing.
    RNA. 2004 Jul;10(7):1119-29 PMID: 15208447
  48. Structure of spliceosomal snRNPs and their role in pre-mRNA splicing.
    Biochim Biophys Acta. 1990 Nov 30;1087(3):265-92 PMID: 2147394
  49. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines.
    J Virol. 2003 Jan;77(2):1392-402 PMID: 12502855
  50. Proteomics analysis of human astrocytes expressing the HIV protein Tat.
    Brain Res Mol Brain Res. 2005 Feb 18;133(2):307-16 PMID: 15710248
  51. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity.
    J Immunol. 2004 Sep 15;173(6):3838-43 PMID: 15356131
  52. Sam68 is absolutely required for Rev function and HIV-1 production.
    Nucleic Acids Res. 2005 Feb 08;33(3):873-9 PMID: 15701759
  53. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.
    EMBO J. 1999 Jul 15;18(14):4060-7 PMID: 10406810
  54. Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterization.
    Virology. 2002 Jun 20;298(1):84-95 PMID: 12093176
  55. Sorting out the complexity of SR protein functions.
    RNA. 2000 Sep;6(9):1197-211 PMID: 10999598
  56. Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.
    J Virol. 2003 Aug;77(16):8819-30 PMID: 12885901
  57. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity.
    J Virol. 1999 Jan;73(1):608-17 PMID: 9847366
  58. Selective restriction of Nef-defective human immunodeficiency virus type 1 by a proteasome-dependent mechanism.
    J Virol. 2007 Feb;81(3):1534-6 PMID: 17108041
  59. Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency.
    EMBO J. 2006 Aug 9;25(15):3596-604 PMID: 16874302
  60. Maternal-fetal feline immunodeficiency virus transmission: timing and tissue tropisms.
    J Infect Dis. 1998 Oct;178(4):960-7 PMID: 9806022
  61. Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter- and cell-specific manner.
    Virology. 2003 Sep 15;314(1):179-89 PMID: 14517071
  62. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.
    Science. 1987 Feb 13;235(4790):790-3 PMID: 3643650
  63. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.
    J Biol Chem. 2004 Mar 12;279(11):10077-84 PMID: 14703516
  64. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
    J Biol Chem. 2001 Nov 2;276(44):40464-75 PMID: 11526107
  65. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments.
    FEBS Lett. 2004 Aug 27;573(1-3):83-92 PMID: 15327980
Article Info
Journal
Virology
Abbr.
Virology
ISSN
0042-6822
Published
2008-02-20
Epub
2007-00-25
Pages
394-404
Language
English
Region
United States
NLM ID
0110674
PMCID
PMC2255568
Subset
IM
Grants
NIMH NIH HHS · P50 MH047680-090001 · United States
NIAID NIH HHS · R01 AI040882 · United States
NINDS NIH HHS · T32 NS041219-05 · United States
NIAID NIH HHS · R01 AI040882-06 · United States
NIGMS NIH HHS · P01 GM048870-070005 · United States
NINDS NIH HHS · T32 NS041219-04 · United States
NIAID NIH HHS · R01 AI048411-04A2 · United States
NIAID NIH HHS · R01 AI048411-07 · United States
NIAID NIH HHS · R01 AI048411-03 · United States
NIMH NIH HHS · P30 MH062261-059006 · United States
NIAID NIH HHS · R01 AI040882-05A2 · United States
NIAID NIH HHS · R01 AI040882-09 · United States
NIGMS NIH HHS · P01 GM048870 · United States
NINDS NIH HHS · T32 NS041219 · United States
NIMH NIH HHS · P50 MH047680-10S10001 · United States
NINDS NIH HHS · T32 NS041219-07 · United States
NIAID NIH HHS · R01 AI025825-18 · United States
NIMH NIH HHS · P30 MH062261 · United States
NIGMS NIH HHS · P01 GM048870-100005 · United States
NIAID NIH HHS · R01 AI025825-19 · United States
NIAID NIH HHS · R01 AI048411-02 · United States
NIAID NIH HHS · R01 AI040882-08 · United States
NIMH NIH HHS · P50 MH047680-080001 · United States
NIAID NIH HHS · R01 AI040882-04 · United States
NIAID NIH HHS · R01 AI025825-15A1 · United States
NIAID NIH HHS · R01 AI025825-14 · United States
NINDS NIH HHS · T32 NS041219-03 · United States
NIGMS NIH HHS · P01 GM048870-119002 · United States
NIAID NIH HHS · R01 AI025825-16 · United States
NIGMS NIH HHS · P01 GM048870-080005 · United States
NCRR NIH HHS · P41 RR008605-138300 · United States
NIAID NIH HHS · R01 AI040882-03 · United States
NIAID NIH HHS · R01 AI048411-06 · United States
NCRR NIH HHS · P41 RR008605 · United States
NIAID NIH HHS · R01 AI025825-13 · United States
NIMH NIH HHS · P30 MH062261-019006 · United States
NINDS NIH HHS · T32 NS041219-02 · United States
NIGMS NIH HHS · P01 GM048870-060005 · United States
NIMH NIH HHS · P50 MH047680-09S10001 · United States
NIAID NIH HHS · R01 AI025825-17 · United States
NIAID NIH HHS · R01 AI025825-20A2 · United States
NIAID NIH HHS · R21 AI049128-01 · United States
NIMH NIH HHS · P30 MH062261-039006 · United States
NINDS NIH HHS · T32 NS041219-06 · United States
NIMH NIH HHS · P50 MH047680-100001 · United States
NIAID NIH HHS · R01 AI025825 · United States
NIAID NIH HHS · R01 AI040882-07 · United States
NIMH NIH HHS · P30 MH062261-029006 · United States
NIAID NIH HHS · R01 AI025825-21 · United States
NIAID NIH HHS · R01 AI048411-01 · United States
NIAID NIH HHS · R01 AI048411 · United States
NINDS NIH HHS · T32 NS041219-01 · United States
NIGMS NIH HHS · P01 GM048870-090005 · United States
NIAID NIH HHS · R01 AI048411-05 · United States
NIMH NIH HHS · P30 MH062261-049006 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]